Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 14 studies | 29% ± 13% | |
| oligodendrocyte | 12 studies | 31% ± 12% | |
| glutamatergic neuron | 11 studies | 40% ± 27% | |
| oligodendrocyte precursor cell | 11 studies | 32% ± 14% | |
| astrocyte | 11 studies | 33% ± 17% | |
| GABAergic neuron | 9 studies | 38% ± 24% | |
| microglial cell | 9 studies | 26% ± 9% | |
| interneuron | 6 studies | 42% ± 23% | |
| macrophage | 6 studies | 33% ± 8% | |
| fibroblast | 6 studies | 25% ± 10% | |
| neuron | 5 studies | 29% ± 14% | |
| epithelial cell | 5 studies | 33% ± 12% | |
| adipocyte | 5 studies | 21% ± 4% | |
| granule cell | 4 studies | 24% ± 3% | |
| endothelial cell of lymphatic vessel | 4 studies | 28% ± 5% | |
| pericyte | 4 studies | 22% ± 8% | |
| smooth muscle cell | 4 studies | 18% ± 1% | |
| GABAergic interneuron | 3 studies | 27% ± 3% | |
| retinal ganglion cell | 3 studies | 28% ± 12% | |
| myeloid cell | 3 studies | 19% ± 3% | |
| ciliated cell | 3 studies | 21% ± 3% | |
| neural progenitor cell | 3 studies | 19% ± 1% | |
| monocyte | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2861.28 | 2642 / 2642 | 100% | 14.19 | 704 / 705 |
| prostate | 100% | 2195.94 | 245 / 245 | 100% | 7.91 | 500 / 502 |
| esophagus | 100% | 2236.40 | 1445 / 1445 | 99% | 6.69 | 182 / 183 |
| breast | 100% | 2746.37 | 459 / 459 | 99% | 10.40 | 1110 / 1118 |
| thymus | 100% | 2585.63 | 653 / 653 | 99% | 9.15 | 600 / 605 |
| lung | 100% | 2177.64 | 578 / 578 | 99% | 7.17 | 1145 / 1155 |
| uterus | 100% | 2759.51 | 170 / 170 | 98% | 7.55 | 452 / 459 |
| kidney | 100% | 1903.54 | 89 / 89 | 98% | 9.33 | 886 / 901 |
| bladder | 100% | 2380.10 | 21 / 21 | 97% | 6.37 | 491 / 504 |
| skin | 100% | 2886.47 | 1809 / 1809 | 97% | 10.67 | 456 / 472 |
| adrenal gland | 100% | 2837.35 | 258 / 258 | 97% | 7.86 | 222 / 230 |
| stomach | 100% | 1753.81 | 359 / 359 | 96% | 5.47 | 274 / 286 |
| pancreas | 97% | 1091.69 | 319 / 328 | 98% | 5.77 | 175 / 178 |
| intestine | 100% | 2322.39 | 966 / 966 | 95% | 5.01 | 501 / 527 |
| ovary | 100% | 2832.62 | 180 / 180 | 95% | 5.18 | 407 / 430 |
| liver | 100% | 958.62 | 225 / 226 | 85% | 3.81 | 347 / 406 |
| adipose | 100% | 2610.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2689.77 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.12 | 29 / 29 |
| spleen | 100% | 2405.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 8.32 | 45 / 45 |
| muscle | 100% | 1759.65 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 1346.27 | 832 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 1836.17 | 870 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 5.60 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042149 | Biological process | cellular response to glucose starvation |
| GO_0006897 | Biological process | endocytosis |
| GO_0030242 | Biological process | autophagy of peroxisome |
| GO_0006622 | Biological process | protein targeting to lysosome |
| GO_0000045 | Biological process | autophagosome assembly |
| GO_0006497 | Biological process | protein lipidation |
| GO_0034497 | Biological process | protein localization to phagophore assembly site |
| GO_0044829 | Biological process | positive regulation by host of viral genome replication |
| GO_0016236 | Biological process | macroautophagy |
| GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
| GO_0051301 | Biological process | cell division |
| GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
| GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
| GO_0010506 | Biological process | regulation of autophagy |
| GO_0006914 | Biological process | autophagy |
| GO_0016241 | Biological process | regulation of macroautophagy |
| GO_0045022 | Biological process | early endosome to late endosome transport |
| GO_0097352 | Biological process | autophagosome maturation |
| GO_0032465 | Biological process | regulation of cytokinesis |
| GO_0030496 | Cellular component | midbody |
| GO_0016020 | Cellular component | membrane |
| GO_0044754 | Cellular component | autolysosome |
| GO_0035032 | Cellular component | phosphatidylinositol 3-kinase complex, class III |
| GO_0005777 | Cellular component | peroxisome |
| GO_0005930 | Cellular component | axoneme |
| GO_0005829 | Cellular component | cytosol |
| GO_0034272 | Cellular component | phosphatidylinositol 3-kinase complex, class III, type II |
| GO_0034271 | Cellular component | phosphatidylinositol 3-kinase complex, class III, type I |
| GO_0005776 | Cellular component | autophagosome |
| GO_0000407 | Cellular component | phagophore assembly site |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005770 | Cellular component | late endosome |
| GO_0030670 | Cellular component | phagocytic vesicle membrane |
| GO_0005768 | Cellular component | endosome |
| GO_0052742 | Molecular function | phosphatidylinositol kinase activity |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| GO_0016301 | Molecular function | kinase activity |
| GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PIK3C3 |
| Protein name | Phosphatidylinositol 3-kinase catalytic subunit type 3 (EC 2.7.1.137) Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34) Phosphatidylinositol 3-kinase catalytic subunit type 3 phosphatidylinositol 3-kinase (EC 2.7.1.137) |
| Synonyms | VPS34 |
| Description | FUNCTION: Catalytic subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis . As part of PI3KC3-C1, promotes endoplasmic reticulum membrane curvature formation prior to vesicle budding . Involved in regulation of degradative endocytic trafficking and required for the abcission step in cytokinesis, probably in the context of PI3KC3-C2 . Involved in the transport of lysosomal enzyme precursors to lysosomes (By similarity). Required for transport from early to late endosomes (By similarity). .; FUNCTION: (Microbial infection) Kinase activity is required for SARS coronavirus-2/SARS-CoV-2 replication. . |
| Accessions | K7EKH3 ENST00000398870.7 ENST00000597477.5 A0A0B4J2B1 ENST00000586545.5 M0R386 K7ENH3 ENST00000587402.2 A8MYT4 M0R308 ENST00000585528.5 ENST00000589056.5 ENST00000262039.9 K7EIV6 ENST00000591011.1 Q8NEB9 |